Development of Drug Delivery Systems Based on Layered Hydroxides for Nanomedicine

被引:52
|
作者
Barahuie, Farahnaz [1 ]
Hussein, Mohd Zobir [1 ]
Fakurazi, Sharida [2 ,3 ]
Zainal, Zulkarnain [1 ]
机构
[1] Univ Putra Malaysia, Mat Synth & Characterizat Lab, Inst Adv Technol ITMA, Serdang 43400, Malaysia
[2] Univ Putra Malaysia, Inst Biosci, Lab Vaccines & Immunotherapeut, Serdang 43400, Malaysia
[3] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang 43400, Malaysia
关键词
layered hydroxides; nanomedicine; drug delivery; nanocomposite; nanocarrier; LDH; ZLH; cytotoxicity assay; CONVERTING-ENZYME-INHIBITORS; CONTROLLED-RELEASE PROPERTY; IN-VITRO; COMPARATIVE TOXICITY; NANOHYBRID COMPOUND; CELLULAR TOXICITY; SUSTAINED-RELEASE; ANTICANCER DRUG; UREA HYDROLYSIS; CAFFEIC ACID;
D O I
10.3390/ijms15057750
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Layered hydroxides (LHs) have recently fascinated researchers due to their wide application in various fields. These inorganic nanoparticles, with excellent features as nanocarriers in drug delivery systems, have the potential to play an important role in healthcare. Owing to their outstanding ion-exchange capacity, many organic pharmaceutical drugs have been intercalated into the interlayer galleries of LHs and, consequently, novel nanodrugs or smart drugs may revolutionize in the treatment of diseases. Layered hydroxides, as green nanoreservoirs with sustained drug release and cell targeting properties hold great promise of improving health and prolonging life.
引用
收藏
页码:7750 / 7786
页数:37
相关论文
共 50 条
  • [41] Nanomedicine strategies for drug delivery to the ear
    Pritz, Christian Oliver
    Dudas, Jozsef
    Rask-Andersen, Helge
    Schrott-Fischer, Anneliese
    Glueckert, Rudolf
    [J]. NANOMEDICINE, 2013, 8 (07) : 1155 - 1172
  • [42] NANOMEDICINE-INNOVATE DRUG DELIVERY
    Brayden, D. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 25 - 26
  • [43] Intrathecal drug delivery in the era of nanomedicine
    Fowler, M. J.
    Cotter, J. D.
    Knight, B. E.
    Sevick-Muraca, E. M.
    Sandberg, D. I.
    Sirianni, R. W.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2020, 165-166 : 77 - 95
  • [44] Nanomedicine and drug delivery: a mini review
    Mirza, Agha Zeeshan
    Siddiqui, Farhan Ahmed
    [J]. INTERNATIONAL NANO LETTERS, 2014, 4 (01) : 94 - U59
  • [45] Nanomedicine and drug delivery: a mini review
    Agha Zeeshan Mirza
    Farhan Ahmed Siddiqui
    [J]. International Nano Letters, 2014, 4 (1)
  • [46] Nanomedicine and Nanoscale Drug Delivery (NND)
    Lee, Yong-kyu
    Han, Dong-Wook
    [J]. 2019 13TH IEEE INTERNATIONAL CONFERENCE ON NANO/MOLECULAR MEDICINE & ENGINEERING (IEEE-NANOMED 2019), 2019, : 81 - 81
  • [47] Ocular drug delivery: nanomedicine applications
    Vandervoort, Jo
    Ludwig, Annick
    [J]. NANOMEDICINE, 2007, 2 (01) : 11 - 21
  • [48] Cell-based drug-delivery systems: a possible solution to improve nanomedicine for cancer treatment?
    Chan, Wei-Jen
    Li, Huatian
    Dehestani, Sina
    [J]. NANOMEDICINE, 2022, 17 (06) : 349 - 352
  • [49] Development of gene drug delivery systems based on pharmacokinetic studies
    Takakura, Y
    Nishikawa, M
    Yamashita, F
    Hashida, M
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (01) : 71 - 76
  • [50] Development of buccal drug delivery systems based on a thiolated polymer
    Langoth, N
    Kalbe, J
    Bernkop-Schnürch, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) : 141 - 148